Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
342 participants
OBSERVATIONAL
2014-07-31
2018-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
NCT01186133
Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent
NCT05044273
Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice
NCT05981911
CONNECT DES Registrty
NCT04715594
Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents
NCT03507205
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IRIS DeSyne
DeSyne drug eluting stent group
DeSyne drug eluting stent group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DeSyne drug eluting stent group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Intervention with DeSyne drug eluting coronary stent
* Agreed with written informed consent form
Exclusion Criteria
* Life expectancy of 1year and under
* Cardiac shock
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CardioVascular Research Foundation, Korea
OTHER
Amg Korea Co. Ltd.
INDUSTRY
Seung-Jung Park
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seung-Jung Park
MD,PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sam Anyang Hospital
Anyang, , South Korea
Soon Chun Hyang University Hospital Bucheon
Cheonan, , South Korea
Chungbuk National University Hospital
Cheongju-si, , South Korea
Hallym University Chuncheon Sacred Heart Hospital
Chuncheon, , South Korea
Kangwon National University Hospital
Chuncheon, , South Korea
Konkuk University Chungju hospital
Chungju, , South Korea
Daegu Catholic University Medical Center
Daegu, , South Korea
Keimyung University Dongsan Medical Center
Daegu, , South Korea
The Catholic University of Korea, Daejeon ST. Mary's Hospital
Daejeon, , South Korea
Gangneung Asan Hospital
Gangneung, , South Korea
Chonnam National University Hospital
Gwangju, , South Korea
Gachon University Gil Hospital
Incheon, , South Korea
Kwangju Christian Hospital
Kwangju, , South Korea
Asan Medical Center
Seoul, , South Korea
Gangnam Severance Hospital
Seoul, , South Korea
Kangdong Sacred Heart Hospital
Seoul, , South Korea
Korea University Guro Hospital
Seoul, , South Korea
Seoul Veterans Hospital
Seoul, , South Korea
St.carollo Hospital
Suncheon, , South Korea
Ulsan University Hospital
Ulsan, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AMCCV2014-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.